RUVASTAT

Ruvastat

RUVASTAT

Rosuvastatin

ABBOTT LABORATORIES (PAKISTAN) LIMITED.

Drug Identity

Active Ingredient
Rosuvastatin
Drug Class
Cardiac Care
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Severe renal impairment
Active liver disease including elevated serum transaminases, myopathy, risk of renal failure secondary to rhabdomyolysis, hypothyroidism, history of hereditary muscle disorders, history of muscle toxicity with a statin or fibrate, alcohol abuse

Important Warnings

Severe hepatic impairment, history of liver disease
Monitor liver function before and 3 months after starting treatment, Advise patients to report unexplained muscle weakness or pain
monitor creatine kinase levels, renal impairment, elderly (more than 70 years)

Side Effects

ProteinuriaGynaecomastiahaematuriaoedemaStevens-Johnson syndromeheadachedizzinessGI upsetmyalgiaanaesthesia.

Drug Interactions

Gemfibrozil
fibrates
nicotinic acid
cyclosporin
azole antifungals
protease inhibitors
macrolides
warfarin

Pregnancy & Lactation

Pregnancy
Contraindicated in pregnancy.
Lactation
Not recommended.

Price Intelligence

Rs 154.4
Servaid observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 154.4

Should you consider an alternative?

Other options containing Rosuvastatin, and what they are not.You pay Rs 78 more than the cheapest equivalent

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.